Association of Cannabis Use Disorder Versus Other Substance Use Disorders With Psychiatric Conditions: A Propensity-Matched Retrospective Cohort Analysis
| Journal | The American journal of psychiatry |
| Study Type | Cohort |
| Population | Human participants |
This large-scale retrospective analysis challenges prevailing assumptions about cannabis use disorder’s psychiatric risk profile compared to other substance use disorders. The findings suggest CUD may carry lower mental health risks than commonly believed, which has important implications for clinical risk stratification and treatment planning.
Using the TriNetX Research Network, researchers compared mental health outcomes between patients with cannabis use disorder (CUD) only versus other substance use disorders, employing propensity score matching across 345,903 adult patients per cohort. Adults with isolated CUD showed significantly lower rates of subsequent schizophrenia (0.34% vs 0.42%), depression (1.35% vs 1.74%), and psychotic disorders (0.36% vs 0.52%) compared to those with other SUDs. The study design controls for demographic factors and 24 comorbidities, though residual confounding and the observational nature limit causal inference.
“While this data doesn’t minimize CUD’s clinical significance, it does suggest our relative concern about psychiatric sequelae may be disproportionate compared to other substances. I find this useful for contextualizing risk discussions with patients and families.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
Does cannabis use disorder carry the same psychiatric risk as other substance use disorders?
No, this large retrospective cohort study found that adults with cannabis use disorder alone had significantly lower risks of developing schizophrenia, depression, and psychotic disorders compared to those with other substance use disorders. The relative risk reductions were substantial, with 19% lower risk for schizophrenia and 22% lower risk for depression.
Yes, the study examined both adult and pediatric populations separately, suggesting that age may influence the relationship between cannabis use disorder and subsequent psychiatric conditions. However, the study design specifically compared different age groups to account for developmental considerations in substance use outcomes.
How does having multiple substance use disorders affect psychiatric risk in cannabis users?
The study specifically analyzed adults with cannabis use disorder plus another substance use disorder versus those with multiple non-cannabis substance use disorders. This comparison helps clinicians understand whether cannabis adds additional psychiatric risk when combined with other substances.
What psychiatric conditions should clinicians monitor most closely in patients with cannabis use disorder?
Based on this study’s findings, clinicians should monitor for schizophrenia, depression, and psychotic disorders, as these were the specific mental health outcomes measured. While cannabis use disorder showed lower risk than other SUDs, these conditions still occurred and require clinical vigilance.
How should these findings influence substance use disorder treatment planning?
These results suggest that cannabis use disorder may have a different psychiatric risk profile compared to other substance use disorders, potentially informing risk stratification and monitoring approaches. However, clinicians should continue comprehensive psychiatric screening regardless of substance type, as mental health complications can still occur across all substance use disorders.
